<DOC>
	<DOC>NCT00000232</DOC>
	<brief_summary>The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.</brief_summary>
	<brief_title>Alternate Day Buprenorphine Administration, Phase IX - 14</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>April 1994</verification_date>
</DOC>